 |
Altasciences is a forward-thinking, mid-size contract research organization offering pharmaceutical and biotechnology companies of all sizes a proven, flexible approach to preclinical and early phase clinical studies, from lead candidate selection to proof of concept. For over 25 years, Altasciences has been integrating into clients’ projects to help support educated, faster, and more complete early drug development decisions. Altasciences’ full-service solutions include preclinical safety testing, clinical pharmacology, bioanalysis, program management, medical writing, biostatistics, data management and more, all of which can be tailored to specific sponsor requirements. Altasciences… helping sponsors get better drugs to the people who need them, faster.
Exhibit #: 1
|
|
BioPharma Services Inc is a client-focused, regulatory-inspected contract research organization specializing in Bioequivalence studies and Phase I/IIa (including Abuse Liability, Alcohol and DD Interaction, FIM, SAD/MAD) Clinical Trials, with a total of 300 beds split between our clinical sites in Canada and the USA. We are a physician-owned, full-service provider with support services in Regulatory and Scientific Affairs, PK Design and Support, Medical Writing, Data Management/Biostatistics and Bioanalytical services.
Exhibit #: 17
|
|
dMed, founded in Shanghai in 2016, has grown to nearly 500 professionals covering 12 China cities and three US offices. As a global full service clinical CRO, we are committed to delivering regulatory, clinical research including biometrics, pharmacovigilance and clinical pharmacology services at global standard from both China and US.
Exhibit #: 2
|
 |
Frontage is a CRO providing integrated, scientifically-driven research, analytical and product development services throughout the drug discovery and development process to enable biopharmaceutical companies to achieve their drug development goals. We offer our clients comprehensive services in analytical testing and formulation development, drug metabolism and pharmacokinetics (DMPK), bioanalysis, preclinical safety and toxicology and early phase clinical studies.
Exhibit #: 19
|
|
High Point Clinical Trials Center has provided comprehensive (Phase I-III) clinical site services since 2008. Our 42,000 ft2 facility consists of three units for the execution of outpatient and inpatient studies. In addition to Healthy Normal, HPCTC focuses on specialty populations such as Metabolic Diseases, NASH, Renal Impairment, Respiratory and Nicotine.
Exhibit #: 10
|
|
HUGHES & Associates LLC is your comprehensive executive search firm servicing the pharmaceutical and biotechnology industries. Whether your needs are finding a highly specialized candidate or enhancing your career, we are prepared to accept and complete your most challenging assignments.
Exhibit #: 13
|
|
Metrum Research Group is the leading innovator in biomedical modeling and simulation. We have provided strategic decision making with the highest quality of scientific expertise for 150+ companies on over 550 projects. Visit our exhibit booth to learn about how we aim to defeat disease by taking a quantitative approach to drug development. Ask about job openings including Modeling & Simulation Scientist and Clinical Pharmacologist positions.
Exhibit #: 16
|
|
NOCCR and VRG are privately-owned, multispecialty clinical research centers which are members of the Alliance for Multispecialty Research. NOCCR-Knoxville is a fully-equipped Phase I Unit with 50 beds and 24,500+ sq ft of space located within the University of Tennessee Medical Center. This unit excels at FIH, procedurally-complex trials and special populations. VRG and NOCCR-New Orleans primarily conduct later-phase studies in a broad array of therapeutic areas.
Exhibit #: 5
|
 |
Nuventra is a drug development consulting firm specializing in pharmacokinetics, pharmacodynamics and pharmacometrics. Our 30+ consultants, most with over 15 years of experience, serve as a virtual extension of your team. More than just providing results from an analysis, our group helps make those results actionable and provides strategic guidance throughout your development program.
Exhibit #: 11 |
|
qPharmetra LLC, a global leader in pharmacometric modeling, clinical pharmacology consulting and custom software tools, helps drug companies make better development decisions resulting in better medicines. qPharmetra’s core values of creativity, consistency and collaboration ensure that clients receive appropriate and repeatable analysis on time to support decision making and regulatory filings. We look forward to talking with you and learning how our team can help you bring your important medicines to patients more quickly.
Exhibit #: 20
|
|
Rudraya Corp is a leading provider of Cloud Computing, Data Management and Visualizations Platform (SONIC) supporting Drug Discovery at Pharmaceutical, Biotechnology and Healthcare organizations. Eight out of the top ten pharma companies are our customers, using SONIC to perform cutting-edge genomics, machine learning, modeling, clinical trial simulation, bioinformatics and other computation workflows.
Exhibit #: 3
|
|
Simulations Plus is the premier developer of modeling & simulation solutions supporting drug discovery and development. With subsidiary companies Cognigen Corp & DILIsym, we provide easy-to-use software (including GastroPlus™, ADMET Predictor™, KIWI™ and DILIsym®) and PBPK modeling, pharmacometrics and systems toxicology/pharmacology consulting to assist with safety risk assessment and preclinical/clinical development efforts.
Exhibit #: 9
|
|
TNO will exhibit the latest developments on the use of microtracer-labeled drugs in clinical pharmacology. Microtracers to establish absolute bioavailability and the application of the automated AMS analysis, combined with simultaneous direct hrMS/MS for metabolite profiling (MIST/mass balance), will be shown. Besides we will showcase in vitro and ex vivo platforms to investigate intestinal permeability, microbiome induced metabolism and biliary excretion/DDIs/hepatic clearance.
Exhibit #: 18
|
|
US Food & Drug Administration - The Office of Clinical Pharmacology (OCP) in the FDA’s Office of Translational Sciences is a multidisciplinary organization of over 200 clinical pharmacologists, pharmacists, researchers, project managers, and administrative staff. OCP’s goals are to enhance drug development, promote regulatory science and innovation, and inform the optimal use of medications.
Exhibit #: 15
|